##GS140550_01 ref_correl: 0.959 (median: 0.971)
##GS140550_01 cnvs: 131 (median: 43)
##GS140550_01 qc_errors: 
#chr	start	end	sample	size	region_count	region_copy_numbers	region_zscores	region_cnv_af	region_coordinates	overlaps_cnp_region	genes	dosage_sensitive_disease_genes	omim
chr1	1960540	1961211	GS140550_01	672	2	3,3	3.01,4.83	0.059,0.033	chr1:1960540-1960715,chr1:1960980-1961211		GABRD	GABRD	137163_[GABRD_(CONFIRMED)_EPILEPSY,GENERALIZED,WITH_FEBRILE_SEIZURES_PLUS,TYPE_5,SUSCEPTIBILITY_TO,613060|EPILEPSY,IDIOPATHIC_GENERALIZED,10,613060|EPILEPSY,JUVENILE_MYOCLONIC,SUSCEPTIBILITY_TO,613060]
chr1	6534501	6534657	GS140550_01	157	1	3	3.79	0.052	chr1:6534501-6534657		PLEKHG5		611101_[PLEKHG5_(CONFIRMED)_SPINAL_MUSCULAR_ATROPHY,DISTAL,AUTOSOMAL_RECESSIVE,4,611067|CHARCOT-MARIE-TOOTH_DISEASE,RECESSIVE_INTERMEDIATE_C,615376]
chr1	17326885	17327039	GS140550_01	155	1	3	4.86	0.059	chr1:17326885-17327039		ATP13A2		610513_[ATP13A2_(CONFIRMED)_KUFOR-RAKEB_SYNDROME,606693|SPASTIC_PARAPLEGIA_78,AUTOSOMAL_RECESSIVE,617225]
chr1	22154513	22154655	GS140550_01	143	1	1	-3.84	0.020	chr1:22154513-22154655		HSPG2	HSPG2	142461_[HSPG2_(CONFIRMED)_SCHWARTZ-JAMPEL_SYNDROME,TYPE_1,255800|DYSSEGMENTAL_DYSPLASIA,SILVERMAN-HANDMAKER_TYPE,224410]
chr1	22183498	22183888	GS140550_01	391	2	1,1	-4.36,-2.65	0.013,0.013	chr1:22183498-22183698,chr1:22183768-22183888		HSPG2	HSPG2	142461_[HSPG2_(CONFIRMED)_SCHWARTZ-JAMPEL_SYNDROME,TYPE_1,255800|DYSSEGMENTAL_DYSPLASIA,SILVERMAN-HANDMAKER_TYPE,224410]
chr1	22204669	22204756	GS140550_01	88	1	3	3.61	0.039	chr1:22204669-22204756		HSPG2	HSPG2	142461_[HSPG2_(CONFIRMED)_SCHWARTZ-JAMPEL_SYNDROME,TYPE_1,255800|DYSSEGMENTAL_DYSPLASIA,SILVERMAN-HANDMAKER_TYPE,224410]
chr1	26136164	26136321	GS140550_01	158	1	3	4.37	0.065	chr1:26136164-26136321		SELENON		606210_[SEPN1_(CONFIRMED)_MUSCULAR_DYSTROPHY,RIGID_SPINE,1,602771|MYOPATHY,CONGENITAL,WITH_FIBER-TYPE_DISPROPORTION,255310]
chr1	43408887	43409002	GS140550_01	116	1	3	4.41	0.033	chr1:43408887-43409002		SLC2A1	SLC2A1	138140_[SLC2A1_(CONFIRMED)_GLUT1_DEFICIENCY_SYNDROME_1,INFANTILE_ONSET,SEVERE,606777|GLUT1_DEFICIENCY_SYNDROME_2,CHILDHOOD_ONSET,612126|EPILEPSY,IDIOPATHIC_GENERALIZED,SUSCEPTIBILITY_TO,12,614847|DYSTONIA_9,601042|STOMATIN-DEFICIENT_CRYOHYDROCYTOSIS_WITH_NEUROLOGIC_DEFECTS,608885]
chr1	100361832	100366427	GS140550_01	4596	2	3,3	3.58,2.54	0.046,0.046	chr1:100361832-100361954,chr1:100366182-100366427		AGL		610860_[AGL_(CONFIRMED)_GLYCOGEN_STORAGE_DISEASE_IIIA,232400|GLYCOGEN_STORAGE_DISEASE_IIIB,232400]
chr1	150776487	150776725	GS140550_01	239	1	3	3.97	0.065	chr1:150776487-150776725		CTSK		601105_[CTSK_(PROVISIONAL)_PYCNODYSOSTOSIS,265800]
chr1	216462612	216465722	GS140550_01	3111	2	3,3	2.76,4.05	0.046,0.072	chr1:216462612-216462762,chr1:216465507-216465722		USH2A		608400_[USH2A_(CONFIRMED)_USHER_SYNDROME,TYPE_2A,276901|RETINITIS_PIGMENTOSA_39,613809]
chr2	106468194	106471755	GS140550_01	3562	2	3,3	6.13,2.32	0.065,0.052	chr2:106468194-106468363,chr2:106471494-106471755		NCK2	NCK2	
chr2	109398974	109399328	GS140550_01	355	1	3	3.58	0.033	chr2:109398974-109399328		RANBP2		601181_[RANBP2_(PROVISIONAL)_ENCEPHALOPATHY,ACUTE,INFECTION-INDUCED,3,SUSCEPTIBILITY_TO,608033]
chr2	152437987	152438111	GS140550_01	125	1	3	3.53	0.059	chr2:152437987-152438111		NEB		161650_[NEB_(CONFIRMED)_NEMALINE_MYOPATHY_2,AUTOSOMAL_RECESSIVE,256030]
chr2	152482038	152484358	GS140550_01	2321	3	3,3,3	2.81,2.98,5.14	0.085,0.098,0.072	chr2:152482038-152482162,chr2:152483506-152483729,chr2:152484027-152484358		NEB		161650_[NEB_(CONFIRMED)_NEMALINE_MYOPATHY_2,AUTOSOMAL_RECESSIVE,256030]
chr2	152496859	152497190	GS140550_01	332	1	3	4.47	0.072	chr2:152496859-152497190		NEB		161650_[NEB_(CONFIRMED)_NEMALINE_MYOPATHY_2,AUTOSOMAL_RECESSIVE,256030]
chr2	152500322	152500653	GS140550_01	332	1	3	4.43	0.065	chr2:152500322-152500653		NEB		161650_[NEB_(CONFIRMED)_NEMALINE_MYOPATHY_2,AUTOSOMAL_RECESSIVE,256030]
chr2	179547414	179547640	GS140550_01	227	1	3	3.81	0.098	chr2:179547414-179547640		TTN,TTN-AS1		188840_[TTN_(CONFIRMED)_CARDIOMYOPATHY,FAMILIAL_HYPERTROPHIC,9,613765|CARDIOMYOPATHY,DILATED,1G,604145|TIBIAL_MUSCULAR_DYSTROPHY,TARDIVE,600334|MUSCULAR_DYSTROPHY,LIMB-GIRDLE,TYPE_2J,608807|MYOPATHY,PROXIMAL,WITH_EARLY_RESPIRATORY_MUSCLE_INVOLVEMENT,603689|SALIH_MYOPATHY,611705]
chr2	202608971	202609162	GS140550_01	192	1	3	4.25	0.052	chr2:202608971-202609162		ALS2		606352_[ALS2_(CONFIRMED)_AMYOTROPHIC_LATERAL_SCLEROSIS_2,JUVENILE,205100|PRIMARY_LATERAL_SCLEROSIS,JUVENILE,606353|SPASTIC_PARALYSIS,INFANTILE_ONSET_ASCENDING,607225]
chr2	211082679	211082836	GS140550_01	158	1	3	4.01	0.039	chr2:211082679-211082836		ACADL		
chr2	215815593	215815817	GS140550_01	225	1	3	5.54	0.052	chr2:215815593-215815817		ABCA12		607800_[ABCA12_(CONFIRMED)_ICHTHYOSIS,CONGENITAL,AUTOSOMAL_RECESSIVE_4A,601277|ICHTHYOSIS,CONGENITAL,AUTOSOMAL_RECESSIVE_4B_(HARLEQUIN),242500]
chr2	233407582	233407802	GS140550_01	221	1	3	3.75	0.046	chr2:233407582-233407802		CHRNG		100730_[CHRNG_(CONFIRMED)_ESCOBAR_SYNDROME,265000|MULTIPLE_PTERYGIUM_SYNDROME,LETHAL_TYPE,253290]
chr3	4829621	4829833	GS140550_01	213	1	3	4.04	0.026	chr3:4829621-4829833		ITPR1	ITPR1	147265_[ITPR1_(CONFIRMED)_SPINOCEREBELLAR_ATAXIA_15,606658|SPINOCEREBELLAR_ATAXIA_29,CONGENITAL_NONPROGRESSIVE,117360|GILLESPIE_SYNDROME,206700]
chr3	8775476	8775686	GS140550_01	211	1	3	3.72	0.052	chr3:8775476-8775686		CAV3		601253_[CAV3_(CONFIRMED)_MUSCULAR_DYSTROPHY,LIMB-GIRDLE,TYPE_IC,607801|RIPPLING_MUSCLE_DISEASE,606072|CREATINE_PHOSPHOKINASE,ELEVATED_SERUM,123320|MYOPATHY,DISTAL,TATEYAMA_TYPE,614321|CARDIOMYOPATHY,FAMILIAL_HYPERTROPHIC,192600|LONG_QT_SYNDROME_9,611818]
chr3	48607557	48607777	GS140550_01	221	2	3,3	3.92,2.84	0.039,0.039	chr3:48607557-48607621,chr3:48607698-48607777		COL7A1		120120_[COL7A1_(CONFIRMED)_EPIDERMOLYSIS_BULLOSA_DYSTROPHICA,AD,131750|EPIDERMOLYSIS_BULLOSA_DYSTROPHICA,AR,226600|EPIDERMOLYSIS_BULLOSA,PRETIBIAL,131850|EBD,BART_TYPE,132000|EBD,LOCALISATA_VARIANT|TRANSIENT_BULLOUS_OF_THE_NEWBORN,131705|EPIDERMOLYSIS_BULLOSA_PRURIGINOSA,604129|TOENAIL_DYSTROPHY,ISOLATED,607523|EBD_INVERSA,226600]
chr3	48617208	48617257	GS140550_01	50	1	1	-3.57	0.020	chr3:48617208-48617257		COL7A1		120120_[COL7A1_(CONFIRMED)_EPIDERMOLYSIS_BULLOSA_DYSTROPHICA,AD,131750|EPIDERMOLYSIS_BULLOSA_DYSTROPHICA,AR,226600|EPIDERMOLYSIS_BULLOSA,PRETIBIAL,131850|EBD,BART_TYPE,132000|EBD,LOCALISATA_VARIANT|TRANSIENT_BULLOUS_OF_THE_NEWBORN,131705|EPIDERMOLYSIS_BULLOSA_PRURIGINOSA,604129|TOENAIL_DYSTROPHY,ISOLATED,607523|EBD_INVERSA,226600]
chr3	48629525	48629910	GS140550_01	386	2	1,1	-3.17,-3.76	0.020,0.020	chr3:48629525-48629691,chr3:48629774-48629910		COL7A1		120120_[COL7A1_(CONFIRMED)_EPIDERMOLYSIS_BULLOSA_DYSTROPHICA,AD,131750|EPIDERMOLYSIS_BULLOSA_DYSTROPHICA,AR,226600|EPIDERMOLYSIS_BULLOSA,PRETIBIAL,131850|EBD,BART_TYPE,132000|EBD,LOCALISATA_VARIANT|TRANSIENT_BULLOUS_OF_THE_NEWBORN,131705|EPIDERMOLYSIS_BULLOSA_PRURIGINOSA,604129|TOENAIL_DYSTROPHY,ISOLATED,607523|EBD_INVERSA,226600]
chr3	58067346	58067513	GS140550_01	168	1	3	4.30	0.039	chr3:58067346-58067513		FLNB		603381_[FLNB_(CONFIRMED)_SPONDYLOCARPOTARSAL_SYNOSTOSIS_SYNDROME,272460|LARSEN_SYNDROME,150250|ATELOSTEOGENESIS,TYPE_I,108720|ATELOSTEOGENESIS,TYPE_III,108721|BOOMERANG_DYSPLASIA,112310]
chr3	184075140	184075285	GS140550_01	146	1	1	-3.71	0.046	chr3:184075140-184075285		CLCN2,EIF2B5	CLCN2	600570_[CLCN2_(CONFIRMED)_EPILEPSY,JUVENILE_MYOCLONIC,SUSCEPTIBILITY_TO,8,607628|EPILEPSY,JUVENILE_ABSENCE,SUSCEPTIBILITY_TO,2,607628|EPILEPSY,IDIOPATHIC_GENERALIZED,SUSCEPTIBILITY_TO,11,607628|LEUKOENCEPHALOPATHY_WITH_ATAXIA,615651]
chr4	1986525	1986656	GS140550_01	132	1	3	4.93	0.072	chr4:1986525-1986656		NELFA	NELFA	
chr5	1432569	1432823	GS140550_01	255	1	3	5.67	0.078	chr5:1432569-1432823		SLC6A3		126455_[SLC6A3_(CONFIRMED)_NICOTINE_DEPENDENCE,PROTECTION_AGAINST,188890|PARKINSONISM-DYSTONIA,INFANTILE,613135]
chr5	40958125	40958373	GS140550_01	249	1	3	4.16	0.052	chr5:40958125-40958373		C7		217070_[C7_(CONFIRMED)_C7_DEFICIENCY,610102]
chr5	68840721	68840956	GS140550_01	236	1	5	5.54	0.026	chr5:68840721-68840956	yes	OCLN		602876_[OCLN_(CONFIRMED)_PSEUDO-TORCH_SYNDROME_1,251290]
chr5	77511869	77512071	GS140550_01	203	1	3	3.70	0.059	chr5:77511869-77512071		AP3B1		603401_[AP3B1_(PROVISIONAL)_HERMANSKY-PUDLAK_SYNDROME_2,608233]
chr5	90072260	90072403	GS140550_01	144	1	3	3.68	0.072	chr5:90072260-90072403		ADGRV1	ADGRV1	602851_[GPR98_(CONFIRMED)_FEBRILE_SEIZURES,FAMILIAL,4,604352|USHER_SYNDROME,TYPE_2C,605472|USHER_SYNDROME,TYPE_2C,GPR98/PDZD7_DIGENIC,605472]
chr5	127599107	127599358	GS140550_01	252	1	3	3.64	0.085	chr5:127599107-127599358		FBN2		612570_[FBN2_(PROVISIONAL)_CONTRACTURAL_ARACHNODACTYLY,CONGENITAL,121050|MACULAR_DEGENERATION,EARLY-ONSET,616118]
chr6	31963486	31964848	GS140550_01	1363	5	1,1,1,1,1	-2.36,-4.53,-2.75,-2.51,-4.75	0.072,0.105,0.098,0.098,0.085	chr6:31963486-31963581,chr6:31963722-31963898,chr6:31963974-31964110,chr6:31964196-31964387,chr6:31964596-31964848	yes	C4A	C4A	120810_[C4A_(CONFIRMED)_C4A_DEFICIENCY,614380|BLOOD_GROUP,RODGERS,614374]
chr6	33414342	33414573	GS140550_01	232	1	3	4.10	0.039	chr6:33414342-33414573		SYNGAP1	SYNGAP1	603384_[SYNGAP1_(CONFIRMED)_MENTAL_RETARDATION,AUTOSOMAL_DOMINANT_5,612621]
chr6	43550043	43550888	GS140550_01	846	2	3,3	2.30,3.59	0.013,0.020	chr6:43550043-43550203,chr6:43550734-43550888		POLH		603968_[POLH_(CONFIRMED)_XERODERMA_PIGMENTOSUM,VARIANT_TYPE,278750]
chr6	51929743	51929858	GS140550_01	116	1	3	5.95	0.046	chr6:51929743-51929858		PKHD1		606702_[PKHD1_(CONFIRMED)_POLYCYSTIC_KIDNEY_AND_HEPATIC_DISEASE,263200]
chr6	52905924	52906216	GS140550_01	293	1	3	3.68	0.007	chr6:52905924-52906216		ICK		612325_[ICK_(PROVISIONAL)_ENDOCRINE-CEREBROOSTEODYSPLASIA,612651]
chr6	132189148	132189276	GS140550_01	129	1	3	4.52	0.059	chr6:132189148-132189276		ENPP1		173335_[ENPP1_(CONFIRMED)_DIABETES_MELLITUS,NON-INSULIN-DEPENDENT,SUSCEPTIBILITY_TO,125853|OBESITY,SUSCEPTIBILITY_TO,601665|ARTERIAL_CALCIFICATION,GENERALIZED,OF_INFANCY,1,208000|HYPOPHOSPHATEMIC_RICKETS,AUTOSOMAL_RECESSIVE,2,613312|COLE_DISEASE,615522]
chr6	143780212	143780363	GS140550_01	152	1	3	3.54	0.065	chr6:143780212-143780363		PEX3		603164_[PEX3_(CONFIRMED)_PEROXISOME_BIOGENESIS_DISORDER_10A_(ZELLWEGER),614882|PEROXISOME_BIOGENESIS_DISORDER_10B,617370]
chr6	157431596	157431705	GS140550_01	110	1	3	3.97	0.039	chr6:157431596-157431705		ARID1B	ARID1B	614556_[ARID1B_(CONFIRMED)_COFFIN-SIRIS_SYNDROME_1,135900]
chr6	157510766	157510924	GS140550_01	159	1	3	3.83	0.046	chr6:157510766-157510924		ARID1B	ARID1B	614556_[ARID1B_(CONFIRMED)_COFFIN-SIRIS_SYNDROME_1,135900]
chr6	161128722	161128848	GS140550_01	127	1	3	4.01	0.039	chr6:161128722-161128848		PLG		173350_[PLG_(CONFIRMED)_DYSPLASMINOGENEMIA,217090|PLASMINOGEN_DEFICIENCY,TYPE_I,217090]
chr7	195544	195742	GS140550_01	199	1	3	3.66	0.039	chr7:195544-195742		FAM20C		611061_[FAM20C_(CONFIRMED)_RAINE_SYNDROME,259775]
chr7	42065788	42066021	GS140550_01	234	1	4	7.35	0.085	chr7:42065788-42066021		GLI3	GLI3	165240_[GLI3_(CONFIRMED)_GREIG_CEPHALOPOLYSYNDACTYLY_SYNDROME,175700|PALLISTER-HALL_SYNDROME,146510|POLYDACTYLY,PREAXIAL,TYPE_IV,174700|POLYDACTYLY,POSTAXIAL,TYPES_A1_AND_B,174200|HYPOTHALAMIC_HAMARTOMAS,SOMATIC,241800]
chr7	50566836	50566950	GS140550_01	115	1	1	-4.12	0.052	chr7:50566836-50566950		DDC		107930_[DDC_(CONFIRMED)_AROMATIC_L-AMINO_ACID_DECARBOXYLASE_DEFICIENCY,608643]
chr7	65444704	65444908	GS140550_01	205	1	3	4.01	0.007	chr7:65444704-65444908		GUSB		611499_[GUSB_(CONFIRMED)_MUCOPOLYSACCHARIDOSIS_VII,253220]
chr7	66459189	66459338	GS140550_01	150	1	3	3.62	0.026	chr7:66459189-66459338		SBDS		607444_[SBDS_(CONFIRMED)_SHWACHMAN-DIAMOND_SYNDROME,260400|APLASTIC_ANEMIA,SUSCEPTIBILITY_TO,609135]
chr7	73474696	73474841	GS140550_01	146	1	3	4.46	0.078	chr7:73474696-73474841		ELN	ELN	130160_[ELN_(CONFIRMED)_SUPRAVALVAR_AORTIC_STENOSIS,185500|CUTIS_LAXA,AUTOSOMAL_DOMINANT,123700],608512_[NCF1_(PROVISIONAL)_CHRONIC_GRANULOMATOUS_DISEASE_DUE_TO_DEFICIENCY_OF_NCF-1,233700]
chr7	74160666	74160760	GS140550_01	95	1	1	-3.50	0.092	chr7:74160666-74160760		GTF2I,STAG3L2	GTF2I	608512_[NCF1_(PROVISIONAL)_CHRONIC_GRANULOMATOUS_DISEASE_DUE_TO_DEFICIENCY_OF_NCF-1,233700]
chr7	74171142	74171203	GS140550_01	62	1	3	4.72	0.052	chr7:74171142-74171203		GTF2I,STAG3L2	GTF2I	608512_[NCF1_(PROVISIONAL)_CHRONIC_GRANULOMATOUS_DISEASE_DUE_TO_DEFICIENCY_OF_NCF-1,233700]
chr7	74195116	74195191	GS140550_01	76	1	1	-5.64	0.072	chr7:74195116-74195191		NCF1,STAG3L2	NCF1	608512_[NCF1_(PROVISIONAL)_CHRONIC_GRANULOMATOUS_DISEASE_DUE_TO_DEFICIENCY_OF_NCF-1,233700]
chr7	114268585	114268742	GS140550_01	158	1	3	3.86	0.085	chr7:114268585-114268742		FOXP2	FOXP2	605317_[FOXP2_(CONFIRMED)_SPEECH-LANGUAGE_DISORDER-1,602081]
chr7	114282455	114282688	GS140550_01	234	1	3	4.53	0.026	chr7:114282455-114282688		FOXP2	FOXP2	605317_[FOXP2_(CONFIRMED)_SPEECH-LANGUAGE_DISORDER-1,602081]
chr7	114298111	114298332	GS140550_01	222	1	4	4.86	0.105	chr7:114298111-114298332		FOXP2	FOXP2	605317_[FOXP2_(CONFIRMED)_SPEECH-LANGUAGE_DISORDER-1,602081]
chr7	117250563	117251872	GS140550_01	1310	2	3,3	2.60,4.09	0.033,0.078	chr7:117250563-117250733,chr7:117251625-117251872		CFTR		602421_[CFTR_(CONFIRMED)_CYSTIC_FIBROSIS,219700|CONGENITAL_BILATERAL_ABSENCE_OF_VAS_DEFERENS,277180|SWEAT_CHLORIDE_ELEVATION_WITHOUT_CF|PANCREATITIS,IDIOPATHIC,167800|HYPERTRYPSINEMIA,NEONATAL|BRONCHIECTASIS_WITH_OR_WITHOUT_ELEVATED_SWEAT_CHLORIDE_1,MODIFIER_OF,211400]
chr7	142997463	142997543	GS140550_01	81	1	1	-3.82	0.065	chr7:142997463-142997543		CASP2		
chr7	143043223	143043354	GS140550_01	132	1	3	4.74	0.046	chr7:143043223-143043354		CLCN1	CLCN1	118425_[CLCN1_(PROVISIONAL)_MYOTONIA_CONGENITA,RECESSIVE,255700|MYOTONIA_CONGENITA,DOMINANT,160800|MYOTONIA_LEVIOR,RECESSIVE]
chr8	22020077	22020255	GS140550_01	179	1	3	4.95	0.085	chr8:22020077-22020255		SFTPC		178620_[SFTPC_(CONFIRMED)_SURFACTANT_METABOLISM_DYSFUNCTION,PULMONARY,2,610913]
chr8	38282017	38282227	GS140550_01	211	1	3	4.29	0.052	chr8:38282017-38282227		FGFR1	FGFR1	136350_[FGFR1_(CONFIRMED)_PFEIFFER_SYNDROME,101600|JACKSON-WEISS_SYNDROME,123150|HYPOGONADOTROPIC_HYPOGONADISM_2_WITH_OR_WITHOUT_ANOSMIA,147950|OSTEOGLOPHONIC_DYSPLASIA,166250|TRIGONOCEPHALY_1,190440|HARTSFIELD_SYNDROME,615465|ENCEPHALOCRANIOCUTANEOUS_LIPOMATOSIS,613001]
chr9	732368	732627	GS140550_01	260	1	3	5.92	0.039	chr9:732368-732627		KANK1	KANK1	607704_[KANK1_(CONFIRMED)_CEREBRAL_PALSY,SPASTIC_QUADRIPLEGIC,2,612900]
chr9	135786379	135786510	GS140550_01	132	1	3	4.77	0.039	chr9:135786379-135786510		TSC1	TSC1	605284_[TSC1_(CONFIRMED)_TUBEROUS_SCLEROSIS-1,191100|LYMPHANGIOLEIOMYOMATOSIS,606690|FOCAL_CORTICAL_DYSPLASIA,TYPE_II,SOMATIC,607341]
chr10	43615519	43615661	GS140550_01	143	1	3	4.53	0.059	chr10:43615519-43615661		RET	RET	164761_[RET_(CONFIRMED)_MULTIPLE_ENDOCRINE_NEOPLASIA_IIA,171400|MEDULLARY_THYROID_CARCINOMA,155240|MULTIPLE_ENDOCRINE_NEOPLASIA_IIB,162300|CENTRAL_HYPOVENTILATION_SYNDROME,CONGENITAL,209880|PHEOCHROMOCYTOMA,171300|HIRSCHSPRUNG_DISEASE,SUSCEPTIBILITY_TO,1,142623]
chr10	73269829	73269991	GS140550_01	163	1	3	3.78	0.026	chr10:73269829-73269991		CDH23,CDH23-AS1		605516_[CDH23_(CONFIRMED)_USHER_SYNDROME,TYPE_1D,601067|DEAFNESS,AUTOSOMAL_RECESSIVE_12,601386|USHER_SYNDROME,TYPE_1D/F_DIGENIC,601067]
chr11	1780736	1780879	GS140550_01	144	1	3	5.60	0.118	chr11:1780736-1780879		CTSD		116840_[CTSD_(CONFIRMED)_CEROID_LIPOFUSCINOSIS,NEURONAL,10,610127]
chr11	65638618	65638844	GS140550_01	227	1	3	4.54	0.105	chr11:65638618-65638844		EFEMP2		604633_[EFEMP2_(PROVISIONAL)_CUTIS_LAXA,AUTOSOMAL_RECESSIVE,TYPE_IB,614437]
chr11	68125108	68125325	GS140550_01	218	1	3	4.94	0.046	chr11:68125108-68125325		LRP5		603506_[LRP5_(CONFIRMED)_OSTEOPOROSIS-PSEUDOGLIOMA_SYNDROME,259770|BONE_MINERAL_DENSITY_VARIABILITY_1,601884|HYPEROSTOSIS,ENDOSTEAL,144750|VAN_BUCHEM_DISEASE,TYPE_2,607636|OSTEOSCLEROSIS,144750|OSTEOPOROSIS,166710|EXUDATIVE_VITREORETINOPATHY_4,601813|OSTEOPETROSIS,AUTOSOMAL_DOMINANT_1,607634]
chr11	68549229	68549437	GS140550_01	209	1	3	4.05	0.007	chr11:68549229-68549437		CPT1A		600528_[CPT1A_(CONFIRMED)_CPT_DEFICIENCY,HEPATIC,TYPE_IA,255120]
chr11	71152263	71152496	GS140550_01	234	1	3	4.51	0.020	chr11:71152263-71152496		DHCR7	DHCR7	602858_[DHCR7_(CONFIRMED)_SMITH-LEMLI-OPITZ_SYNDROME,270400]
chr11	76873156	76873386	GS140550_01	231	1	3	3.77	0.007	chr11:76873156-76873386		MYO7A		276903_[MYO7A_(CONFIRMED)_USHER_SYNDROME,TYPE_1B,276900|DEAFNESS,AUTOSOMAL_RECESSIVE_2,600060|DEAFNESS,AUTOSOMAL_DOMINANT_11,601317]
chr12	971239	971446	GS140550_01	208	1	3	4.14	0.052	chr12:971239-971446		WNK1		605232_[WNK1_(CONFIRMED)_PSEUDOHYPOALDOSTERONISM,TYPE_IIC,614492|NEUROPATHY,HEREDITARY_SENSORY_AND_AUTONOMIC,TYPE_II,201300]
chr12	7361591	7361776	GS140550_01	186	1	3	4.10	0.052	chr12:7361591-7361776		PEX5		600414_[PEX5_(CONFIRMED)_PEROXISOME_BIOGENESIS_DISORDER_2A_(ZELLWEGER),214110|PEROXISOME_BIOGENESIS_DISORDER_2B,202370|RHIZOMELIC_CHONDRODYSPLASIA_PUNCTATA,TYPE_5,616716]
chr12	25378538	25380356	GS140550_01	1819	2	3,3	2.66,4.81	0.052,0.052	chr12:25378538-25378717,chr12:25380158-25380356		KRAS		190070_[KRAS_(CONFIRMED)_LUNG_CANCER,SOMATIC,211980|BLADDER_CANCER,SOMATIC,109800|PANCREATIC_CARCINOMA,SOMATIC,260350|GASTRIC_CANCER,SOMATIC,137215|LEUKEMIA,ACUTE_MYELOID,601626|NOONAN_SYNDROME_3,609942|CARDIOFACIOCUTANEOUS_SYNDROME_2,615278|BREAST_CANCER,SOMATIC,114480|SCHIMMELPENNING-FEUERSTEIN-MIMS_SYNDROME,SOMATIC_MOSAIC,163200|RAS-ASSOCIATED_AUTOIMMUNE_LEUKOPROLIFERATIVE_DISORDER,614470]
chr12	41331362	41331499	GS140550_01	138	1	3	4.52	0.072	chr12:41331362-41331499		CNTN1		600016_[CNTN1_(PROVISIONAL)_MYOPATHY,CONGENITAL,COMPTON-NORTH,612540]
chr12	49428183	49428269	GS140550_01	87	1	1	-3.74	0.033	chr12:49428183-49428269		KMT2D	KMT2D	602113_[KMT2D_(PROVISIONAL)_KABUKI_SYNDROME_1,147920]
chr12	56092157	56092370	GS140550_01	214	1	3	3.99	0.085	chr12:56092157-56092370		ITGA7		600536_[ITGA7_(PROVISIONAL)_MUSCULAR_DYSTROPHY,CONGENITAL,DUE_TO_ITGA7_DEFICIENCY,613204]
chr12	57966353	57966519	GS140550_01	167	1	3	3.73	0.039	chr12:57966353-57966519		KIF5A		602821_[KIF5A_(CONFIRMED)_SPASTIC_PARAPLEGIA_10,AUTOSOMAL_DOMINANT,604187|MYOCLONUS,INTRACTABLE,NEONATAL,617235]
chr12	110231725	110231837	GS140550_01	113	1	3	3.73	0.020	chr12:110231725-110231837		TRPV4		605427_[TRPV4_(CONFIRMED)_BRACHYOLMIA_TYPE_3,113500|SPONDYLOMETAPHYSEAL_DYSPLASIA,KOZLOWSKI_TYPE,184252|METATROPIC_DYSPLASIA,156530|HEREDITARY_MOTOR_AND_SENSORY_NEUROPATHY,TYPE_IIC,606071|SCAPULOPERONEAL_SPINAL_MUSCULAR_ATROPHY,181405|SODIUM_SERUM_LEVEL_QTL_1,613508|PARASTREMMATIC_DWARFISM,168400|SED,MAROTEAUX_TYPE,184095|SPINAL_MUSCULAR_ATROPHY,DISTAL,CONGENITAL_NONPROGRESSIVE,600175|DIGITAL_ARTHROPATHY-BRACHYDACTYLY,FAMILIAL,606835|AVASCULAR_NECROSIS_OF_FEMORAL_HEAD,PRIMARY,2,617383]
chr12	111893823	111894070	GS140550_01	248	1	3	5.81	0.065	chr12:111893823-111894070		ATXN2		601517_[ATXN2_(CONFIRMED)_SPINOCEREBELLAR_ATAXIA_2,183090|AMYOTROPHIC_LATERAL_SCLEROSIS,SUSCEPTIBILITY_TO,13,183090|PARKINSON_DISEASE,LATE-ONSET,SUSCEPTIBILITY_TO,168600]
chr13	32652961	32653180	GS140550_01	220	1	3	3.77	0.020	chr13:32652961-32653180		FRY		
chr13	111009809	111009909	GS140550_01	101	1	3	3.60	0.046	chr13:111009809-111009909		COL4A2		120090_[COL4A2_(CONFIRMED)_PORENCEPHALY_2,614483|HEMORRHAGE,INTRACEREBRAL,SUSCEPTIBILITY_TO,614519]
chr15	48541762	48541883	GS140550_01	122	1	3	3.56	0.039	chr15:48541762-48541883		SLC12A1	SLC12A1	600839_[SLC12A1_(CONFIRMED)_BARTTER_SYNDROME,TYPE_1,601678]
chr15	89826357	89826491	GS140550_01	135	1	3	3.93	0.013	chr15:89826357-89826491		FANCI		611360_[FANCI_(PROVISIONAL)_FANCONI_ANEMIA,COMPLEMENTATION_GROUP_I,609053]
chr16	2155313	2155485	GS140550_01	173	1	3	4.19	0.111	chr16:2155313-2155485	yes	PKD1	PKD1	601313_[PKD1_(CONFIRMED)_POLYCYSTIC_KIDNEY_DISEASE,ADULT_TYPE_I,173900]
chr16	3781767	3786214	GS140550_01	4448	2	3,3	4.47,2.75	0.039,0.026	chr16:3781767-3781948,chr16:3786027-3786214		CREBBP	CREBBP	600140_[CREBBP_(CONFIRMED)_RUBINSTEIN-TAYBI_SYNDROME_1,180849]
chr16	28855261	28855432	GS140550_01	172	1	1	-4.16	0.065	chr16:28855261-28855432		MIR4721,TUFM		602389_[TUFM_(CONFIRMED)_COMBINED_OXIDATIVE_PHOSPHORYLATION_DEFICIENCY_4,610678]
chr16	81397389	81397558	GS140550_01	170	1	3	3.57	0.065	chr16:81397389-81397558		GAN		605379_[GAN_(CONFIRMED)_GIANT_AXONAL_NEUROPATHY-1,256850]
chr17	7754956	7755124	GS140550_01	169	1	1	-3.86	0.026	chr17:7754956-7755124		KDM6B		
chr17	15163957	15165899	GS140550_01	1943	2	4,3	7.68,3.79	0.105,0.072	chr17:15163957-15164103,chr17:15165736-15165899		PMP22	PMP22	601097_[PMP22_(CONFIRMED)_CHARCOT-MARIE-TOOTH_DISEASE,TYPE_1A,118220|DEJERINE-SOTTAS_DISEASE,145900|NEUROPATHY,RECURRENT,WITH_PRESSURE_PALSIES,162500|CHARCOT-MARIE-TOOTH_DISEASE,TYPE_1E,118300|ROUSSY-LEVY_SYNDROME,180800|NEUROPATHY,INFLAMMATORY_DEMYELINATING,139393]
chr17	48267210	48267283	GS140550_01	74	1	1	-3.75	0.046	chr17:48267210-48267283		COL1A1	COL1A1	120150_[COL1A1_(CONFIRMED)_OSTEOGENESIS_IMPERFECTA,TYPE_I,166200|OSTEOGENESIS_IMPERFECTA,TYPE_II,166210|OSTEOGENESIS_IMPERFECTA,TYPE_III,259420|OSTEOGENESIS_IMPERFECTA,TYPE_IV,166220|EHLERS-DANLOS_SYNDROME,CLASSIC,130000|EHLERS-DANLOS_SYNDROME,TYPE_VIIA,130060|CAFFEY_DISEASE,114000|BONE_MINERAL_DENSITY_VARIATION_QTL,OSTEOPOROSIS,166710]
chr17	48268168	48268295	GS140550_01	128	1	3	5.99	0.052	chr17:48268168-48268295		COL1A1	COL1A1	120150_[COL1A1_(CONFIRMED)_OSTEOGENESIS_IMPERFECTA,TYPE_I,166200|OSTEOGENESIS_IMPERFECTA,TYPE_II,166210|OSTEOGENESIS_IMPERFECTA,TYPE_III,259420|OSTEOGENESIS_IMPERFECTA,TYPE_IV,166220|EHLERS-DANLOS_SYNDROME,CLASSIC,130000|EHLERS-DANLOS_SYNDROME,TYPE_VIIA,130060|CAFFEY_DISEASE,114000|BONE_MINERAL_DENSITY_VARIATION_QTL,OSTEOPOROSIS,166710]
chr17	48685178	48685411	GS140550_01	234	1	3	4.56	0.039	chr17:48685178-48685411		CACNA1G		604065_[CACNA1G_(PROVISIONAL)_SPINOCEREBELLAR_ATAXIA_42,616795]
chr17	62036615	62036808	GS140550_01	194	1	3	4.13	0.026	chr17:62036615-62036808		SCN4A		603967_[SCN4A_(CONFIRMED)_HYPERKALEMIC_PERIODIC_PARALYSIS,TYPE_2,170500|PARAMYOTONIA_CONGENITA,168300|MYOTONIA_CONGENITA,ATYPICAL,ACETAZOLAMIDE-RESPONSIVE,608390|MYASTHENIC_SYNDROME,CONGENITAL,16,614198|HYPOKALEMIC_PERIODIC_PARALYSIS,TYPE_2,613345]
chr17	79478919	79479178	GS140550_01	260	1	3	4.10	0.065	chr17:79478919-79479178		ACTG1		102560_[ACTG1_(CONFIRMED)_DEAFNESS,AUTOSOMAL_DOMINANT_20/26,604717|BARAITSER-WINTER_SYNDROME_2,614583]
chr18	33744428	33744640	GS140550_01	213	1	3	3.53	0.046	chr18:33744428-33744640		ELP2		616054_[ELP2_(PROVISIONAL)_MENTAL_RETARDATION,AUTOSOMAL_RECESSIVE_58,617270]
chr18	77457850	77457998	GS140550_01	149	1	3	3.52	0.013	chr18:77457850-77457998		CTDP1		604927_[CTDP1_(PROVISIONAL)_CONGENITAL_CATARACTS,FACIAL_DYSMORPHISM,AND_NEUROPATHY,604168]
chr19	6719212	6719424	GS140550_01	213	1	3	5.22	0.052	chr19:6719212-6719424		C3	C3	120700_[C3_(CONFIRMED)_C3_DEFICIENCY,613779|HEMOLYTIC_UREMIC_SYNDROME,ATYPICAL,SUSCEPTIBILITY_TO,5,612925|MACULAR_DEGENERATION,AGE-RELATED,9,611378]
chr19	11143956	11144203	GS140550_01	248	1	3	4.52	0.078	chr19:11143956-11144203		SMARCA4	SMARCA4	603254_[SMARCA4_(PROVISIONAL)_RHABDOID_TUMOR_PREDISPOSITION_SYNDROME_2,613325|COFFIN-SIRIS_SYNDROME_4,614609]
chr19	11170419	11170571	GS140550_01	153	1	3	3.84	0.072	chr19:11170419-11170571		SMARCA4	SMARCA4	603254_[SMARCA4_(PROVISIONAL)_RHABDOID_TUMOR_PREDISPOSITION_SYNDROME_2,613325|COFFIN-SIRIS_SYNDROME_4,614609]
chr19	38976220	38976852	GS140550_01	633	1	3	3.53	0.046	chr19:38976220-38976852		RYR1		180901_[RYR1_(CONFIRMED)_MALIGNANT_HYPERTHERMIA_SUSCEPTIBILITY_1,145600|CENTRAL_CORE_DISEASE,117000|MINICORE_MYOPATHY_WITH_EXTERNAL_OPHTHALMOPLEGIA,255320|NEUROMUSCULAR_DISEASE,CONGENITAL,WITH_UNIFORM_TYPE_1_FIBER,117000|KING-DENBOROUGH_SYNDROME,145600]
chr19	39002702	39002782	GS140550_01	81	1	1	-4.72	0.065	chr19:39002702-39002782		RYR1		180901_[RYR1_(CONFIRMED)_MALIGNANT_HYPERTHERMIA_SUSCEPTIBILITY_1,145600|CENTRAL_CORE_DISEASE,117000|MINICORE_MYOPATHY_WITH_EXTERNAL_OPHTHALMOPLEGIA,255320|NEUROMUSCULAR_DISEASE,CONGENITAL,WITH_UNIFORM_TYPE_1_FIBER,117000|KING-DENBOROUGH_SYNDROME,145600]
chr19	39014545	39014579	GS140550_01	35	1	1	-3.77	0.065	chr19:39014545-39014579		RYR1		180901_[RYR1_(CONFIRMED)_MALIGNANT_HYPERTHERMIA_SUSCEPTIBILITY_1,145600|CENTRAL_CORE_DISEASE,117000|MINICORE_MYOPATHY_WITH_EXTERNAL_OPHTHALMOPLEGIA,255320|NEUROMUSCULAR_DISEASE,CONGENITAL,WITH_UNIFORM_TYPE_1_FIBER,117000|KING-DENBOROUGH_SYNDROME,145600]
chr19	50364696	50364777	GS140550_01	82	1	1	-3.62	0.033	chr19:50364696-50364777		PNKP		605610_[PNKP_(CONFIRMED)_MICROCEPHALY,SEIZURES,AND_DEVELOPMENTAL_DELAY,613402|ATAXIA-OCULOMOTOR_APRAXIA_4,616267]
chr19	54694109	54694311	GS140550_01	203	1	4	4.24	0.059	chr19:54694109-54694311		TSEN34		608754_[TSEN34_(PROVISIONAL)_PONTOCEREBELLAR_HYPOPLASIA_TYPE_2C,612390]
chr21	33031925	33032164	GS140550_01	240	1	4	4.25	0.183	chr21:33031925-33032164		SOD1		147450_[SOD1_(CONFIRMED)_AMYOTROPHIC_LATERAL_SCLEROSIS_1,105400]
chr21	44485487	44485815	GS140550_01	329	2	1,1	-2.62,-4.85	0.052,0.046	chr21:44485487-44485641,chr21:44485716-44485815		CBS		613381_[CBS_(CONFIRMED)_HOMOCYSTINURIA,B6-RESPONSIVE_AND_NONRESPONSIVE_TYPES,236200|THROMBOSIS,HYPERHOMOCYSTEINEMIC,236200]
chr22	33673036	33673251	GS140550_01	216	1	3	6.15	0.013	chr22:33673036-33673251		LARGE1	LARGE1	603590_[LARGE_(CONFIRMED)_MUSCULAR_DYSTROPHY-DYSTROGLYCANOPATHY_(CONGENITAL_WITH_BRAIN_AND_EYE_ANOMALIES),TYPE_A,6,613154|MUSCULAR_DYSTROPHY-DYSTROGLYCANOPATHY_(CONGENITAL_WITH_MENTAL_RETARDATION),TYPE_B,6,608840]
chrX	6145720	6145898	GS140550_01	179	1	3	3.82	0.039	chrX:6145720-6145898		NLGN4X	NLGN4X	300427_[NLGN4X_(PROVISIONAL)_AUTISM_SUSCEPTIBILITY,X-LINKED_2,300495|ASPERGER_SYNDROME_SUSCEPTIBILITY,X-LINKED_2,300497|MENTAL_RETARDATION,X-LINKED,300495]
chrX	21624887	21625007	GS140550_01	121	1	3	3.89	0.085	chrX:21624887-21625007		CNKSR2		
chrX	32481546	32481721	GS140550_01	176	1	3	4.53	0.026	chrX:32481546-32481721		DMD	DMD	300377_[DMD_(CONFIRMED)_DUCHENNE_MUSCULAR_DYSTROPHY,310200|BECKER_MUSCULAR_DYSTROPHY,300376|CARDIOMYOPATHY,DILATED,3B,302045]
chrX	39930216	39930422	GS140550_01	207	1	3	3.64	0.020	chrX:39930216-39930422		BCOR	BCOR	300485_[BCOR_(CONFIRMED)_MICROPHTHALMIA,SYNDROMIC_2,300166]
chrX	41383194	41383297	GS140550_01	104	1	1	-3.71	0.020	chrX:41383194-41383297		CASK	CASK	300172_[CASK_(CONFIRMED)_MENTAL_RETARDATION_AND_MICROCEPHALY_WITH_PONTINE_AND_CEREBELLAR_HYPOPLASIA,300749|FG_SYNDROME_4,300422|MENTAL_RETARDATION,WITH_OR_WITHOUT_NYSTAGMUS,300422]
chrX	41782173	41782297	GS140550_01	125	1	3	4.30	0.046	chrX:41782173-41782297		CASK	CASK	300172_[CASK_(CONFIRMED)_MENTAL_RETARDATION_AND_MICROCEPHALY_WITH_PONTINE_AND_CEREBELLAR_HYPOPLASIA,300749|FG_SYNDROME_4,300422|MENTAL_RETARDATION,WITH_OR_WITHOUT_NYSTAGMUS,300422]
chrX	47028704	47028907	GS140550_01	204	1	3	4.90	0.033	chrX:47028704-47028907		RBM10		300080_[RBM10_(PROVISIONAL)_TARP_SYNDROME,311900]
chrX	47062930	47063105	GS140550_01	176	1	3	3.82	0.020	chrX:47062930-47063105		UBA1		314370_[UBA1_(CONFIRMED)_SPINAL_MUSCULAR_ATROPHY,X-LINKED_2,INFANTILE,301830]
chrX	47082941	47083168	GS140550_01	228	1	3	5.28	0.085	chrX:47082941-47083168		CDK16		
chrX	49071792	49072013	GS140550_01	222	1	3	4.80	0.065	chrX:49071792-49072013		CACNA1F		300110_[CACNA1F_(CONFIRMED)_NIGHT_BLINDNESS,CONGENITAL_STATIONARY_(INCOMPLETE),2A,X-LINKED,300071|CONE-ROD_DYSTROPHY,X-LINKED,3,300476|ALAND_ISLAND_EYE_DISEASE,300600]
chrX	49079378	49079605	GS140550_01	228	1	3	3.82	0.033	chrX:49079378-49079605		CACNA1F		300110_[CACNA1F_(CONFIRMED)_NIGHT_BLINDNESS,CONGENITAL_STATIONARY_(INCOMPLETE),2A,X-LINKED,300071|CONE-ROD_DYSTROPHY,X-LINKED,3,300476|ALAND_ISLAND_EYE_DISEASE,300600]
chrX	49840440	49840647	GS140550_01	208	1	3	3.95	0.039	chrX:49840440-49840647		CLCN5	CLCN5	300008_[CLCN5_(CONFIRMED)_DENT_DISEASE,300009|NEPHROLITHIASIS,TYPE_I,310468|HYPOPHOSPHATEMIC_RICKETS,300554|PROTEINURIA,LOW_MOLECULAR_WEIGHT,WITH_HYPERCALCIURIC_NEPHROCALCINOSIS,308990]
chrX	53224403	53224602	GS140550_01	200	1	1	-4.33	0.033	chrX:53224403-53224602		KDM5C	KDM5C	314690_[KDM5C_(CONFIRMED)_MENTAL_RETARDATION,X-LINKED,SYNDROMIC,CLAES-JENSEN_TYPE,300534]
chrX	53421688	53421818	GS140550_01	131	1	3	4.71	0.039	chrX:53421688-53421818		SMC1A	SMC1A	300040_[SMC1A_(PROVISIONAL)_CORNELIA_DE_LANGE_SYNDROME_2,300590]
chrX	70357566	70357803	GS140550_01	238	1	3	3.70	0.046	chrX:70357566-70357803		MED12		300188_[MED12_(CONFIRMED)_OPITZ-KAVEGGIA_SYNDROME,305450|LUJAN-FRYNS_SYNDROME,309520|OHDO_SYNDROME,X-LINKED,300895]
chrX	84524999	84525162	GS140550_01	164	1	3	3.80	0.039	chrX:84524999-84525162		ZNF711	ZNF711	314990_[ZNF711_(PROVISIONAL)_MENTAL_RETARDATION,X-LINKED_97,300803]
chrX	100077230	100077419	GS140550_01	190	1	3	4.12	0.007	chrX:100077230-100077419		CSTF2		
chrX	110406133	110406284	GS140550_01	152	1	3	3.64	0.059	chrX:110406133-110406284		PAK3	PAK3	300142_[PAK3_(CONFIRMED)_MENTAL_RETARDATION,X-LINKED_30/47,300558]
chrX	128946684	128946806	GS140550_01	123	1	3	3.80	0.007	chrX:128946684-128946806		ZDHHC9	ZDHHC9	300646_[ZDHHC9_(CONFIRMED)_MENTAL_RETARDATION,X-LINKED_SYNDROMIC,RAYMOND_TYPE,300799]
chrX	135076935	135077154	GS140550_01	220	1	3	3.72	0.033	chrX:135076935-135077154		SLC9A6	SLC9A6	300231_[SLC9A6_(CONFIRMED)_MENTAL_RETARDATION,X-LINKED_SYNDROMIC,CHRISTIANSON_TYPE,300243]
chrX	147026379	147026581	GS140550_01	203	1	3	3.61	0.039	chrX:147026379-147026581		FMR1	FMR1	309550_[FMR1_(CONFIRMED)_FRAGILE_X_SYNDROME,300624|FRAGILE_X_TREMOR/ATAXIA_SYNDROME,300623|PREMATURE_OVARIAN_FAILURE_1,311360]
